Sensex, Nifty slip amid pharma tariffs and IT pressure | 26 Sept 2025
Indian markets falter on September 26 as pharma and IT stocks face pressure from US tariff announcements and visa fee concerns. Elevated volatility and mid/smallcap declines highlight cautious investor sentiment. Nifty approaches key support, with defensive sectors eyed for stability.
Sensex, Nifty Slip Amid Pharma Tariffs and IT Pressure | 26 September 2025, 9:25 AM IST
Indian benchmark indices continued their downward trend with Sensex down 383.87 points to 80,775.81 and Nifty falling 124.60 points to 24,766.25. Pharma shares plunged following the US imposing a 100% tariff on branded drug imports, while IT stocks faced pressure amid weak growth outlook and visa fee concerns. Elevated India VIX indicates rising market nervousness.
Snapshot – 9:25 AM IST, 26 September 2025
| Index | Price | Change | % Chg |
|---|---|---|---|
| Sensex | 80,775.81 | -383.87 | -0.47 |
| Nifty 50 | 24,766.25 | -124.60 | -0.50 |
| Nifty Bank | 54,577.30 | -398.90 | -0.73 |
| Nifty IT | 34,000.60 | -547.70 | -1.59 |
| India VIX | 10.96 | 0.18 | 1.67 |
| Nifty Midcap 100 | 56,946.55 | -609.35 | -1.06 |
| Nifty Smallcap 100 | 17,700.00 | -266.80 | -1.48 |
Latest News & Trends
- US imposes 100% tariffs on branded pharmaceutical imports from India, triggering sharp pharma sell-off.
- IT sector under pressure amid concerns over H-1B visa fee hikes and weak growth outlook.
- Midcap and Smallcap indices decline sharply, reflecting risk aversion amid macro uncertainties.
- Defensive sectors and select PSU stocks may see buying interest amid volatility spike.
- Elevated India VIX signals heightened market caution and potential volatility ahead.
Predictions & Watch Outs
- Nifty support expected near 24,700 with resistance at 24,900–25,100.
- Sector focus: Avoid pharma and IT; watch defensive sectors and select PSU stocks for stability.
- Trade strategy: Emphasize risk management and nimble trading amid tariff-driven volatility.
Luwak Technologies – Your trusted partner for insightful, timely market analysis and investment guidance.
